204 related articles for article (PubMed ID: 32875777)
21. Acute Colitis Drives Tolerance by Persistently Altering the Epithelial Barrier and Innate and Adaptive Immunity.
Wardill HR; Choo JM; Dmochowska N; Mavrangelos C; Campaniello MA; Bowen JM; Rogers GB; Hughes PA
Inflamm Bowel Dis; 2019 Jun; 25(7):1196-1207. PubMed ID: 30794280
[TBL] [Abstract][Full Text] [Related]
22. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Curr Protoc Mouse Biol; 2017 Mar; 7(1):13-28. PubMed ID: 28252200
[TBL] [Abstract][Full Text] [Related]
23. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis.
Kozik AJ; Nakatsu CH; Chun H; Jones-Hall YL
PLoS One; 2019; 14(11):e0225079. PubMed ID: 31703107
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Barreiro-de Acosta M; Silva-Rodríguez J; Luzardo-Álvarez A; Herranz M; Otero-Espinar F; Antúnez-López JR; Lamas MJ; Aguiar P; Fernández-Ferreiro A; Ruibal Á
Int J Pharm; 2018 Oct; 549(1-2):335-342. PubMed ID: 30081226
[TBL] [Abstract][Full Text] [Related]
26. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
[TBL] [Abstract][Full Text] [Related]
27. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
[TBL] [Abstract][Full Text] [Related]
28. Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways.
Tang X; Huang G; Zhang T; Li S
Biosci Biotechnol Biochem; 2020 Sep; 84(9):1903-1912. PubMed ID: 32525764
[TBL] [Abstract][Full Text] [Related]
29. A comparative analysis of two models of colitis in rats.
Yamada Y; Marshall S; Specian RD; Grisham MB
Gastroenterology; 1992 May; 102(5):1524-34. PubMed ID: 1314749
[TBL] [Abstract][Full Text] [Related]
30. Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis.
Poli E; Lazzaretti M; Grandi D; Pozzoli C; Coruzzi G
Neurochem Res; 2001 Sep; 26(8-9):1085-93. PubMed ID: 11699935
[TBL] [Abstract][Full Text] [Related]
31. Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats.
El-Salhy M; Hatlebakk JG
Mol Med Rep; 2016 Dec; 14(6):4967-4974. PubMed ID: 27840918
[TBL] [Abstract][Full Text] [Related]
32. The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis.
Peterson TC; Peterson MR; Raoul JM
Eur J Pharmacol; 2011 Jul; 662(1-3):47-54. PubMed ID: 21554874
[TBL] [Abstract][Full Text] [Related]
33. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
34. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
Bennink RJ; van Montfrans C; de Jonge WJ; de Bruin K; van Deventer SJ; te Velde AA
Nucl Med Biol; 2004 Jan; 31(1):93-101. PubMed ID: 14741574
[TBL] [Abstract][Full Text] [Related]
35. Lessons on the Sigma-1 Receptor in TNBS-Induced Rat Colitis: Modulation of the UCHL-1, IL-6 Pathway.
Almási N; Török S; Dvorácskó S; Tömböly C; Csonka Á; Baráth Z; Murlasits Z; Valkusz Z; Pósa A; Varga C; Kupai K
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516975
[TBL] [Abstract][Full Text] [Related]
36. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase.
Salameh E; Meleine M; Gourcerol G; do Rego JC; do Rego JL; Legrand R; Breton J; Aziz M; Guérin C; Coëffier M; Savoye G; Marion-Letellier R
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G692-G700. PubMed ID: 30735453
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance colonography assessment of acute trinitrobenzene sulfonic acid colitis in pre-pubertal rats.
Dupont-Lucas C; Marion-Letellier R; Pala M; Guerin C; Bôle-Feysot C; Salameh E; Goichon A; Nicol L; Aziz M; Savoye-Collet C; Savoye G
PLoS One; 2021; 16(11):e0259135. PubMed ID: 34735489
[TBL] [Abstract][Full Text] [Related]
38. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
[TBL] [Abstract][Full Text] [Related]
39. Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA.
Takagi T; Naito Y; Higashimura Y; Ushiroda C; Mizushima K; Ohashi Y; Yasukawa Z; Ozeki M; Tokunaga M; Okubo T; Katada K; Kamada K; Uchiyama K; Handa O; Itoh Y; Yoshikawa T
Br J Nutr; 2016 Oct; 116(7):1199-1205. PubMed ID: 27604176
[TBL] [Abstract][Full Text] [Related]
40. Chronic Model of Inflammatory Bowel Disease in IL-10
Wang H; Vilches-Moure JG; Cherkaoui S; Tardy I; Alleaume C; Bettinger T; Lutz A; Paulmurugan R
Theranostics; 2019; 9(21):6031-6046. PubMed ID: 31534535
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
